Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology

Robin Bruyndonckx(University of Antwerp), T. Worby(University of Antwerp), Samuel Coenen(University of Antwerp), F.R. Leus, Artur Mierzecki(Pomeranian Medical University), An De Sutter(Ghent University), Herman Goossens(Kaneka (United States)), Katherine Loens(University of Antwerp), N Romano(University of Antwerp), Christine Lammens(Antwerp University Hospital), Renske M. van der Veen(University of Illinois Urbana-Champaign), Marieke Lemiengre(University of Antwerp), Paul Little(University of Antwerp), Theo Verheij(Utrecht University), Niel Hens(University of Antwerp), Anna Kowalczyk(University of Opole), Sławomir Chlabicz(Medical University of Białystok), Michael Moore(Indiana University School of Medicine), M. Ieven(University of Antwerp), Gillian O’Reilly(University of Antwerp), Mateu Serra Prat, Mateusz Muras(University of Antwerp), Christopher Butler(University of Oxford), Melanie J. Davies(NIHR Leicester Biomedical Research Centre), Maciek Godycki-Ćwirko(Medical University of Lodz), Beth Stuart(Queen Mary University of London), G.I.T. Schaberg, A Torres, P. Fernandez(University of Antwerp), Jon Swain(University of Antwerp), Curt Brugman(University Medical Center Utrecht), Kerenza Hood(NHS Digital), I. Hering(University of Antwerp), Jordi Almirall(Hospital Sant Jaume de Calella)
Clinical Microbiology and Infection
November 3, 2017
Cited by 25


Related Papers